If you haven’t read our latest update on the launch of our S3 Pioneer Program, then please do! Now, your journaling activity matters more than ever before
We are so excited for this new chapter of sofi just ahead.
To enable the validation faster with the continuing challenges of the global supply chain (where the central pump in our product has gone from a 10 to a 45-week lead time to supply), we have decided to make some radical changes to our upcoming pioneer programs. We are redirecting the electronics and components of half of the 1,000 ashwagandhas (S3) study to the first alpha testing of a wellness fragrance at the beginning of 2023. This means that we will release our initial study in two waves, one at the beginning of 2023 and a second in the spring when we will have seen the initial results of ashwagandha from the first wave of 500 plant pioneers. So we are splitting into two studies the 1000 participants. Effectively, this means we are oversubscribed by about 50 Pioneers. The most effective solution we can think of is to prioritise those actively journaling in the leadup to the S3, thus giving the sofi brain the best chance of generating results.
The best way to maintain your position in the cue to be in the first wave would be to continue one journal a day. All those who have qualified for a sofi stick will receive one - we will simply prioritise the active journaling members into the first wave in the new year.
We will have more on this shortly, and as far as the timeline for the S3, we are looking at early February.
The expansion to test and validate beyond medicinal plants is a huge step forward for our sofi. And we wanted you to be the first to know of our plans for this. When sofi is finally available to all, she will provide the opportunity for dual relief and mood modulation, all using validated and effective natural and botanical plants and extracts.
We continue to build together.
xx
17 Likes
